Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard H Feldman

Showing results (51-60 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Prevention of Alzheimer'S Disease|January 18, 2025
Tailoring implementation strategies for the healthy actions and lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program: Lessons learned from a survey studySara Moukarzel, Carlos E E Araujo-Menendez, Eliza Galang, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 8, 2018
16-Year Survival of the Canadian Collaborative Cohort of Related DementiasMaya L Lichtenstein, Nader Fallah, Benita Mudge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2025
Seeking optimal repeated fluid biomarker assessments to enhance precision and statistical power in clinical trials: SLIM methodHiroko H Dodge, Liu Chen, Chao-Yi Wu, et al.
Neurobiology of Aging|March 19, 2019
Delayed daily activity and reduced NREM slow-wave power in the APPswe/PS1dE9 mouse model of Alzheimer's diseaseBrianne A Kent, Mateusz Michalik, Elliott G Marchant, et al.
Neural Regeneration Research|October 31, 2025
Cognitive heterogeneity in mild cognitive impairment due to Alzheimer's disease pathologySiyun Chen, David P Salmon, Howard H Feldman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 30, 2020
Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS-Cog-ExecDiane M Jacobs, Ronald G Thomas, David P Salmon, et al.
Neurology|January 10, 2016
Periventricular hyperintensities are associated with elevated cerebral amyloidMichael Marnane, Osama O Al-Jawadi, Shervin Mortazavi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's diseaseJasmine Morales, Nico Gabriel, Loki Natarajan, et al.
Digital Health|November 24, 2025
Exploring the usability and perceived benefits of Brain Health PRO: An online educational program for healthy brain agingGeorge Philip, Alexandra J Fiocco, Sylvie Belleville, et al.
Alzheimer'S Research & Therapy|January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's diseaseJeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
Pageof 16

Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Prevention of Alzheimer'S Disease|January 18, 2025
Tailoring implementation strategies for the healthy actions and lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program: Lessons learned from a survey studySara Moukarzel, Carlos E E Araujo-Menendez, Eliza Galang, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 8, 2018
16-Year Survival of the Canadian Collaborative Cohort of Related DementiasMaya L Lichtenstein, Nader Fallah, Benita Mudge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2025
Seeking optimal repeated fluid biomarker assessments to enhance precision and statistical power in clinical trials: SLIM methodHiroko H Dodge, Liu Chen, Chao-Yi Wu, et al.
Neurobiology of Aging|March 19, 2019
Delayed daily activity and reduced NREM slow-wave power in the APPswe/PS1dE9 mouse model of Alzheimer's diseaseBrianne A Kent, Mateusz Michalik, Elliott G Marchant, et al.
Neural Regeneration Research|October 31, 2025
Cognitive heterogeneity in mild cognitive impairment due to Alzheimer's disease pathologySiyun Chen, David P Salmon, Howard H Feldman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 30, 2020
Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS-Cog-ExecDiane M Jacobs, Ronald G Thomas, David P Salmon, et al.
Neurology|January 10, 2016
Periventricular hyperintensities are associated with elevated cerebral amyloidMichael Marnane, Osama O Al-Jawadi, Shervin Mortazavi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's diseaseJasmine Morales, Nico Gabriel, Loki Natarajan, et al.
Digital Health|November 24, 2025
Exploring the usability and perceived benefits of Brain Health PRO: An online educational program for healthy brain agingGeorge Philip, Alexandra J Fiocco, Sylvie Belleville, et al.
Alzheimer'S Research & Therapy|January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's diseaseJeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
Pageof 16